重症监护病房潜在药物相互作用识别的不一致性:系统评价、批判性评价与报告建议
该系统评价检索MEDLINE数据库,纳入报告ICU患者潜在药物相互作用(pDDI)频率的论文,提取pDDI定义、知识库等方法学选择并评估偏倚风险,将每篇论文按pDDI频率分为低、中、高三组,分析方法学选择与pDDI频率组的关联,并据此制定报告建议。分析显示研究间方法学选择存在显著异质性,65%的研究存在中高度偏倚风险;高偏倚风险、小样本量和使用药物处方而非给药记录与更高的pDDI频率相关。作者认为该评价结果可支持研究者设计可靠的方法学来评估ICU患者pDDI频率,报告建议可能有助于pDDI频率研究的标准化、比较和综合。
要点
- 65%的pDDI频率研究存在中高度偏倚风险,高偏倚风险与更高的pDDI频率相关。
- 小样本量与更高的pDDI频率相关。
- 使用药物处方而非给药记录与更高的pDDI频率相关。
- 研究间pDDI定义和知识库等方法学选择存在显著异质性。
- 作者认为报告建议可能有助于pDDI频率研究的标准化、比较和综合。
适用人群与场景
- 入住重症监护病房(ICU)的患者。
研究设计与关键结果
- 系统评价检索MEDLINE数据库,纳入报告ICU患者pDDI频率的论文,提取pDDI频率及pDDI定义、pDDI知识库等方法学选择,并评估偏倚风险。
- 每篇论文按报告的pDDI频率分为低、中、高三组,分析方法学选择与pDDI频率组的关联,并据此制定报告建议。
- 方法学选择分析显示研究间存在显著异质性,65%的研究存在中高度偏倚风险。
- 高偏倚风险、小样本量和使用药物处方而非给药记录与更高的pDDI频率相关。
证据类型、等级与局限
- 证据类型:系统评价与批判性评价。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该评价结果可支持研究者设计可靠的方法学来评估ICU患者pDDI频率。
- 作者认为报告建议可能有助于pDDI频率研究的标准化、比较和综合,最终改善ICU内外对pDDI的认识。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Patients admitted to the intensive care unit (ICU) are frequently exposed to potential drug-drug interactions (pDDIs). However, reported frequencies of pDDIs in the ICU vary widely between studies. This can be partly explained by significant variation in their methodological approach. Insight into methodological choices affecting pDDI frequency would allow for improved comparison and synthesis of reported pDDI frequencies. This study aimed to evaluate the association between methodological choices and pDDI frequency and formulate reporting recommendations for pDDI frequency studies in the ICU. The MEDLINE database was searched to identify papers reporting pDDI frequency in ICU patients. For each paper, the pDDI frequency and methodological choices such as pDDI definition and pDDI knowledge base were extracted, and the risk of bias was assessed. Each paper was categorized as reporting a low, medium, or high pDDI frequency. We sought associations between methodological choices and pDDI frequency group. Based on this comparison, reporting recommendations were formulated. Analysis of methodological choices showed significant heterogeneity between studies, and 65% of the studies had a medium to high risk of bias. High risk of bias, small sample size, and use of drug prescriptions instead of administrations were related to a higher pDDI frequency. The findings of this review may support researchers in designing a reliable methodology assessing pDDI frequency in ICU patients. The reporting recommendations may contribute to standardization, comparison, and synthesis of pDDI frequency studies, ultimately improving knowledge about pDDIs in and outside the ICU setting.
参考来源
- Bakker T, Dongelmans DA, Nabovati E, et al. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations. J Clin Pharmacol. 2022. PMID: 34957573. doi:10.1002/jcph.2020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。